$CNOB

ConnectOne Bancorp, Inc. (CNOB): Results of Operations and Financial Condition

ConnectOne Bancorp, Inc. (CNOB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_949727.htm EXHIBIT 99.1 ex_949727.htm Exhibit 99.1 CONNECTONE BANCORP, INC. REPORTS SECOND QUARTER 2026 RESULTS OPERATING PERFORMANCE ACCELERATES SEQUENTIAL LOAN GROWTH OF 5% AND CORE DEPOSIT GROWTH OF 8%, ANNUALIZED NET INTEREST MARGIN WIDENS TO 3.42% TANGIBLE BOOK

Original reporting
Published Jul 23, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 11:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CNOB
Bullish
medium confidence
Mentioned
$CNOB
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CNOBBullishMed
01

Why it matters

The most actionable elements are the reported Q2 profitability metrics (net income, EPS, NIM, operating PPNR), the drivers of sequential changes (net interest income, noninterest expense), and the declared common and preferred dividends with record and payment dates.

02

Market read

Sequential loan and core deposit growth accelerated, NIM widened for the 7th consecutive quarter, and dividends were declared, collectively supporting a near-term positive read-through for CNOB’s earnings power and capital return.

03

What to watch

The filing attributes several year-over-year changes to the prior merger with FLIC, so investors may discount parts of the improvement as non-recurring or integration-related.

Relevance 7/10Novelty 7/10Timing: today’s SEC 8-K, before the next earnings call

Background

SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting ConnectOne Bancorp’s second quarter 2026 operating results and financial condition, including dividend declarations.

Company-level read

Ticker impact

$CNOBBullishMedium confidence
Context

ConnectOne Bancorp reported Q2 2026 net income of $40.2M, EPS $0.80, and widened net interest margin to 3.42% with sequential loan growth of 5%.

Expected impact

Likely modest positive bias for near-term trading as NIM expansion and operating efficiency improvements support earnings power, though bank stocks can remain rate-sensitive.

Evidence & confidence

The filing provides multiple concrete datapoints: sequential NIM widening to 3.42%, operating PPNR rising, credit-loss provision increasing vs Q1 but still lower than the prior-year merger-related baseline, and a declared cash dividend with a specific pay/record schedule.

Market effects

Adds another regional bank datapoint on deposit costs and NIM trajectory, relevant to rate and funding-cost expectations.

Limited, but can influence sentiment toward similarly sized Northeast US community banks.

Low; primarily a US small-cap bank earnings and capital-return signal.

Counterpoint

Credit-loss provision rose versus Q1, so the earnings quality may be less durable if asset quality deteriorates.

Key entities

  • ConnectOne Bancorp, Inc.

    Reported Q2 2026 results, including net income of $40.2M, EPS $0.80, NIM widening to 3.42%, and declared dividends.

  • ConnectOne Bank

    Operating bank referenced as the franchise behind the parent’s results.

  • The First of Long Island Corporation (FLIC)

    Merger referenced as a driver of year-over-year changes and prior-year credit provision timing.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.